SunTrust Downgrades Allergen (AGN) to Neutral
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- Wall St rebounds, but yield surge sets stage for weekly losses
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Supermicro probe finds no senior management link to export violations
- Hertz Global amends voting agreement with CK Amarillo after lawsuit
- SpaceX shares fall as second lockup period ends
Ackman Will Withdraw Request for Special Allergan (AGN) Meeting - CNBC
November 18, 2014 10:24 AM ESTPershing Squares Bill Ackman says he's withdrawing his request for a special Allergan (NYSE: AGN) meeting, according to CNBC.
... MoreWells Fargo Downgrades Allergen (AGN) to Market Perform
November 18, 2014 8:00 AM ESTWells Fargo downgraded Allergen (NYSE: AGN) from Outperform to Market Perform.
For an analyst ratings summary and ratings history on Allergen click here. For more ratings news on Allergen click here.
Shares of Allergen closed at $209.20 yesterday.
... MoreWilliam Blair Downgrades Allergen (AGN) to Market Perform
November 18, 2014 6:38 AM ESTWilliam Blair downgraded Allergen (NYSE: AGN) from Outperform to Market Perform.
For an analyst ratings summary and ratings history on Allergen click here. For more ratings news on Allergen click here.
Shares of Allergen closed at $209.20 yesterday.
... MoreGuggenheim Downgrades Allergen (AGN) to Neutral on Takeover
November 18, 2014 6:31 AM ESTGuggenheim downgraded Allergen (NYSE: AGN) from Buy to Neutral but raises its price target to $220.00 following the Actavis (ACT) acqusition.
For an analyst ratings summary and ratings history on Allergen click here. For more ratings news on Allergen click here.
Shares of Allergen closed at $209.20 yesterday.
... MoreActavis (ACT) Agrees to Acquire Allergan (AGN) for ~$219/Share
November 17, 2014 9:15 AM EST(Updated - November 17, 2014 9:16 AM EST)
Actavis plc (NYSE: ACT) and Allergan, Inc. (NYSE: AGN) announced that they have entered into a definitive agreement under which Actavis will acquire Allergan for a combination of $129.22 in cash and 0.3683 Actavis shares for each share of Allergan common stock. Based on the closing price of Actavis shares on November 14, 2014, the transaction is valued at approximately $66 billion, or $219 per Allergan share. The combination will create one of the top 10 global pharmaceutical companies by sales revenue, with combined annual pro forma revenues of more than... More
Actavis (ACT), Allergan (AGN) Said Nearing $62.5B Deal (VRX)
November 16, 2014 3:53 PM ESTActavis plc (NYSE: ACT) is said to be near a $62.5 billion deal to acquire Allergan (NYSE: AGN).
Bloomberg said Sunday that the deal, which as Actavis paying just over $210 per share for... More
